As of 2024-12-15, the EV/EBITDA ratio of STAAR Surgical Co (STAA) is 32.53. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. STAA's latest enterprise value is 1,061.18 mil USD. STAA's TTM EBITDA according to its financial statements is 32.62 mil USD. Dividing these 2 quantities gives us the above STAA EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 12.6x - 17.8x | 14.6x |
| Forward P/E multiples | 16.9x - 20.0x | 18.2x |
| Fair Price | 11.68 - 23.78 | 17.47 |
| Upside | -53.0% - -4.4% | -29.7% |
| Date | EV/EBITDA |
| 2024-12-12 | 33.33 |
| 2024-12-11 | 33.12 |
| 2024-12-10 | 34.92 |
| 2024-12-09 | 34.68 |
| 2024-12-06 | 33.21 |
| 2024-12-05 | 33.10 |
| 2024-12-04 | 34.18 |
| 2024-12-03 | 34.99 |
| 2024-12-02 | 36.85 |
| 2024-11-29 | 38.94 |
| 2024-11-27 | 37.55 |
| 2024-11-26 | 37.36 |
| 2024-11-25 | 38.11 |
| 2024-11-22 | 35.28 |
| 2024-11-21 | 35.20 |
| 2024-11-20 | 34.74 |
| 2024-11-19 | 34.46 |
| 2024-11-18 | 34.83 |
| 2024-11-15 | 35.25 |
| 2024-11-14 | 36.21 |
| 2024-11-13 | 37.94 |
| 2024-11-12 | 38.82 |
| 2024-11-11 | 40.93 |
| 2024-11-08 | 39.68 |
| 2024-11-07 | 42.50 |
| 2024-11-06 | 41.59 |
| 2024-11-05 | 40.33 |
| 2024-11-04 | 39.00 |
| 2024-11-01 | 38.12 |
| 2024-10-31 | 38.77 |
| 2024-10-30 | 39.53 |
| 2024-10-29 | 40.73 |
| 2024-10-28 | 41.34 |
| 2024-10-25 | 40.88 |
| 2024-10-24 | 40.78 |
| 2024-10-23 | 40.58 |
| 2024-10-22 | 40.93 |
| 2024-10-21 | 41.34 |
| 2024-10-18 | 41.90 |
| 2024-10-17 | 41.72 |
| 2024-10-16 | 43.41 |
| 2024-10-15 | 43.50 |
| 2024-10-14 | 44.83 |
| 2024-10-11 | 42.73 |
| 2024-10-10 | 42.09 |
| 2024-10-09 | 42.62 |
| 2024-10-08 | 42.50 |
| 2024-10-07 | 46.64 |
| 2024-10-04 | 47.95 |
| 2024-10-03 | 46.58 |